Omada Health, Inc. income statement OMDA

In fiscal 2025, which ended Dec 31, 2025, Omada Health, Inc. reported revenue of $260.2 million. It recorded a net loss of $12.8 million. The operating loss came to $12.0 million, an operating margin of -4.6%. Diluted earnings per share were -$0.35. Over the twelve months ended Jun 30, 2026, revenue was $309.8 million and net income was $4.3 million.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line
FY 2026
Jun 30, 2026
FY 2025
Dec 31, 2025
Revenue
310
260
Cost of revenue
99
89
Gross profit
211
171
Research and development
49
41
Selling, general and administrative
163
142
Operating expenses
212
183
Operating income
-0
-12
Other income (expense)
5
-1
Pretax income
4
-13
Income tax
0
0
Net income
4
-13
Basic EPS
0.07
-0.35
Diluted EPS
0.07
-0.35
Weighted average shares, basic
58
37
Weighted average shares, diluted
61
37
Other measures
Depreciation and amortization
6
5
EBITDA
5
-6
Interest coverage
-1.17x
-4.72x
Margins
Gross margin
68.19%
65.69%
Operating margin
-0.15%
-4.60%
Pretax margin
1.39%
-4.91%
Profit margin
1.39%
-4.91%
EBITDA margin
1.75%
-2.49%
Effective tax rate
0.00%
—
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

Company profile

Industry
Services-Health Services (SIC 8000)
Listed as
OMDA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
, Emerging growth company
SEC CIK
1611115

Other Services-Health Services companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.